# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012523
Filing Date
2022-08-08
Accepted
2022-08-08 08:00:39
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | qure-20220630x10q.htm iXBRL | 10-Q | 2046026
2 | EX-31.1 | qure-20220630xex31d1.htm | EX-31.1 | 15056
3 | EX-31.2 | qure-20220630xex31d2.htm | EX-31.2 | 15060
4 | EX-32.1 | qure-20220630xex32d1.htm | EX-32.1 | 14743
| Complete submission text file | 0001558370-22-012523.txt |  | 6906830

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | qure-20220630.xsd | EX-101.SCH | 35989
6 | EX-101.CAL | qure-20220630_cal.xml | EX-101.CAL | 45201
7 | EX-101.DEF | qure-20220630_def.xml | EX-101.DEF | 227114
8 | EX-101.LAB | qure-20220630_lab.xml | EX-101.LAB | 405783
9 | EX-101.PRE | qure-20220630_pre.xml | EX-101.PRE | 312685
45 | EXTRACTED XBRL INSTANCE DOCUMENT | qure-20220630x10q_htm.xml | XML | 1143262

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 221142602
SIC: 2834 Pharmaceutical Preparations